Publications by authors named "Bassem Zarif"

Claim this Profile
B
Blood Pressure Variability (BPV): What Clinicians Need to Know a 2025 Expert Consensus Report Endorsed by the Egyptian Society of Cardiology.
Nabil Farag, Ahmed Bendary, Ahmed Shawky Elserafy, Ahmed Tageldien Abdellah, Bassem Zarif

High Blood Press Cardiovasc Prev· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Pharmacogenetics on Renal Outcomes of Heart Failure Patients with Reduced Ejection Fraction (HFrEF) in Response to Dapagliflozin.
Neven Sarhan, Mona F Schaalan, Azza A K El-Sheikh, Bassem Zarif

Pharmaceutics· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immediate and short-term outcomes of in-hospital canagliflozin initiation in acute heart failure: Results from the CANA-AHF randomized clinical trial.
Rabab A El-Gazar, Bassem Zarif, Ahmed Ali Ali, Mira Magdy William, Maggie M Abbassi

Heart Lung· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic polymorphisms in are associated with clinical outcomes and dapagliflozin response in heart failure patients.
Ahmed Essam Abou Warda, Rylie M Flohr, Rania M Sarhan, Mohamed Nabil Salem, Heba F Salem, Bassem Zarif

Front Pharmacol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of health awareness on myocardial infarction.
Ahmed Magdy, Seham Elmarayed, Bassem Zarif, Mohamed Sabry, Ahmed Alsawah

J Egypt Public Health Assoc· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACE Inhibitors and Angiotensin Receptor Blockers for the Primary and Secondary Prevention of Cardiovascular Outcomes: Recommendations from the 2024 Egyptian Cardiology Expert Consensus in Collaboration with the CVREP Foundation.
Mohamed Sobhy, Adel Eletriby, Hany Ragy, Hossam Kandil, Mohamed Ayman Saleh, Bassem Zarif

Cardiol Ther· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravascular ultrasound-guided percutaneous coronary intervention for patients with unprotected left main coronary artery lesions.
Ahmed Bendary, Ahmed Elsaed, Mohamed Abdelshafy Tabl, Khaled Ahmed ElRabat, Bassem Zarif

Coron Artery Dis· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of dapagliflozin on cardiac function following anterior myocardial infarction in non-diabetic patients - DACAMI (a randomized controlled clinical trial).
Khairy Abdel Dayem, Omar Younis, Bassem Zarif, Sameh Attia, Ahmed AbdelSalam

Int J Cardiol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Boosting protection for patients with non-acute cardiovascular disease: a focus on antithrombotic regimen (a consensus expert opinion from the Egyptian Society of Cardiology working group of thrombosis and prevention).
Ahmed Bendary, Bassem Zarif, Hala Mahfouz Badran, Khaled Shokry, Hamza Kabil

Egypt Heart J· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The five keys for a successful implementation of a cardiac telerehabilitation: a step-by-step effective digitalization of rehabilitation health services in Egypt.
Hady Atef, Marwa Gaber, Bassem Zarif

Egypt Heart J· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Testing P2Y12 platelet inhibitors generics beyond bioequivalence: a parallel single-blinded randomized trial.
Bassem Zarif, Lamyaa Soliman, Nirmeen A Sabry, Eman Said

Thromb J· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis